StockData
XBiotech Inc. logo

XBiotech Inc. (XBIT) stock

XBITNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 12, 2026Score 8/30
$1.96+0.00 (0.00%)

Close on Nov 13, 2026Market cap $59.76MP/E –Yield –

XBiotech total assets

Total assets on the balance sheet at the end of each period.

XBiotech's total assets was $128.61M at Sep 30, 2026. For fiscal 2025 it was $150.08M, down 24.6% from the year before. Over ten years it grew 3.2% a year on average. The highest annual figure on record is $816.88M in fiscal 2019.

Annual total assets

PeriodPeriod endValueChange
FY2025Dec 31, 2025$150.08M-24.6%
FY2024Dec 31, 2024$199.09M-12.1%
FY2023Dec 31, 2023$226.62M-7.9%
FY2022Dec 31, 2022$246.10M-10.6%
FY2021Dec 31, 2021$275.18M-22.2%
FY2020Dec 31, 2020$353.74M-56.7%
FY2019Dec 31, 2019$816.88M+1742.1%
FY2018Dec 31, 2018$44.35M-29.6%
FY2017Dec 31, 2017$62.97M-6.1%
FY2016Dec 31, 2016$67.05M-38.7%
FY2015Dec 31, 2015$109.36M+75.9%
FY2014Dec 31, 2014$62.18M–

Quarterly total assets

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q3 FY2026Sep 30, 2026$128.61M-25.4%
Q2 FY2026Jun 30, 2026$133.65M-25.2%
Q1 FY2026Mar 31, 2026$139.84M-23.1%
Q4 FY2025Dec 31, 2025$150.08M-24.6%
Q3 FY2025Sep 30, 2025$172.42M-17.8%
Q2 FY2025Jun 30, 2025$178.68M-17.1%
Q1 FY2025Mar 31, 2025$181.86M-20.2%
Q4 FY2024Dec 31, 2024$199.09M-12.1%
Q3 FY2024Sep 30, 2024$209.85M-8.6%
Q2 FY2024Jun 30, 2024$215.56M-8.3%
Q1 FY2024Mar 31, 2024$227.86M-5.9%
Q4 FY2023Dec 31, 2023$226.62M-7.9%
Q3 FY2023Sep 30, 2023$229.60M-8.5%
Q2 FY2023Jun 30, 2023$235.14M-11.8%
Q1 FY2023Mar 31, 2023$242.12M-10.6%
Q4 FY2022Dec 31, 2022$246.10M-10.6%
Q3 FY2022Sep 30, 2022$250.83M-10.3%
Q2 FY2022Jun 30, 2022$266.46M-24.7%
Q1 FY2022Mar 31, 2022$270.80M-23.9%
Q4 FY2021Dec 31, 2021$275.18M-22.2%
Q3 FY2021Sep 30, 2021$279.52M-20.9%
Q2 FY2021Jun 30, 2021$353.96M-1.3%
Q1 FY2021Mar 31, 2021$355.94M-0.7%
Q4 FY2020Dec 31, 2020$353.74M-56.7%
Q3 FY2020Sep 30, 2020$353.39M+430.3%
Q2 FY2020Jun 30, 2020$358.76M+399.1%
Q1 FY2020Mar 31, 2020$358.37M+799.9%
Q4 FY2019Dec 31, 2019$816.88M+1742.1%
Q3 FY2019Sep 30, 2019$66.64M+35.3%
Q2 FY2019Jun 30, 2019$71.88M+32.4%
Q1 FY2019Mar 31, 2019$39.82M-32.3%
Q4 FY2018Dec 31, 2018$44.35M-29.6%
Q3 FY2018Sep 30, 2018$49.24M-30.3%
Q2 FY2018Jun 30, 2018$54.29M-30.3%
Q1 FY2018Mar 31, 2018$58.86M-32.8%
Q4 FY2017Dec 31, 2017$62.97M-6.1%
Q3 FY2017Sep 30, 2017$70.67M–
Q2 FY2017Jun 30, 2017$77.84M–
Q1 FY2017Mar 31, 2017$87.62M–
Q4 FY2016Dec 31, 2016$67.05M–

More XBiotech figures

See a number that looks wrong?